Various Advanced Cancer Clinical Trial
Official title:
A Two-Cohort, Open-label, Randomized Phase 2 Study of Nivolumab Monotherapy and in Combination With Ipilimumab in Subjects With Advanced or Metastatic, Previously Treated Gastric Gastroesophageal Junction, or Previously Untreated Esophageal Cancer
The main purpose of this study for patients with gastric or gastroesophageal cancer is to
evaluate how well the tumor is responding to treatment with nivolumab by itself, or in
combination with ipilimumab.
For patients with esophageal cancer, the main purpose is to evaluate how well the tumor is
responding to treatment with the combination of nivolumab and ipilimumab.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02488759 -
An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT01986218 -
Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT02387996 -
A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT02632409 -
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
|
Phase 3 | |
| Active, not recruiting |
NCT03143153 -
A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
|
Phase 3 | |
| Completed |
NCT03130959 -
A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies
|
Phase 2 |